Zhang An-Ye, Lai Ching-Lung, Huang Fung-Yu, Seto Wai-Kay, Fung James, Wong Danny Ka-Ho, Yuen Man-Fung
Department of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Department of Medicine, The University of Hong Kong, Hong Kong SAR, China; State Key Laboratory for Liver Research, The University of Hong Kong, Hong Kong SAR, China.
PLoS One. 2015 Sep 30;10(9):e0139478. doi: 10.1371/journal.pone.0139478. eCollection 2015.
Deletions/mutations in the hepatitis B virus (HBV) pre-S region have been associated with hepatocellular carcinoma (HCC). We aimed to study the evolutionary changes of pre-S mutations prior to HCC development.
We studied the HBV pre-S sequences at 1 to 10 years preceding diagnosis of HCC in 74 patients with HBV-related HCC (HCC group). 148 chronic hepatitis B patients matched for sex and age in 2:1 ratio, who had been followed up for at least 3 years without HCC (HCC-free group) were recruited as controls. 56 and 47 patients of HCC and HCC-free groups respectively had serially stored sera for longitudinally examination at 1-3 years, 4-6 years, 7-9 years and ≥10 years prior to the recruitment of the study.
Compared to the HCC-free group, higher frequencies of pre-S deletions and point mutations (at 11 codons) were observed in the HCC group (p<0.05). Multiple logistic regression analysis showed that pre-S deletions, point mutations at codon 51 and 167 were independent factors associated with HCC. Longitudinal observation showed that pre-S deletions and most of the 11 HCC-associated pre-S point mutations existed at least 10 years before HCC development, and were more prevalent preceding HCC development in patients from HCC groups than HCC-free group. The number of HCC-associated pre-S point mutations increased over time preceding HCC development, and correlated positively with the time to HCC diagnosis (r = 0.220, p = 0.005).
High prevalence and cumulative evolution of pre-S mutations preceding HCC development suggested a possible carcinogenic role of pre-S mutations and their potential application in HCC risk prediction.
乙型肝炎病毒(HBV)前S区的缺失/突变与肝细胞癌(HCC)相关。我们旨在研究HCC发生之前前S区突变的进化变化。
我们研究了74例HBV相关HCC患者(HCC组)在HCC诊断前1至10年的HBV前S区序列。招募148例按2:1比例匹配性别和年龄的慢性乙型肝炎患者作为对照,他们至少随访了3年且未发生HCC(无HCC组)。HCC组和无HCC组分别有56例和47例患者在本研究招募前1 - 3年、4 - 6年、7 - 9年及≥10年有连续储存的血清用于纵向检测。
与无HCC组相比,HCC组前S区缺失和点突变(11个密码子处)的频率更高(p<0.05)。多因素logistic回归分析显示,前S区缺失、密码子51和167处的点突变是与HCC相关的独立因素。纵向观察表明,前S区缺失和11个与HCC相关的前S区点突变中的大多数在HCC发生前至少10年就已存在,且在HCC组患者中HCC发生前比无HCC组更普遍。与HCC相关的前S区点突变数量在HCC发生前随时间增加,并与HCC诊断时间呈正相关(r = 0.220,p = 0.005)。
HCC发生之前前S区突变的高发生率和累积进化提示前S区突变可能具有致癌作用及其在HCC风险预测中的潜在应用价值。